This page contains details of ongoing consultations where the opinion and input of BIA members is sought.
If you are commenting on any consultation as an individual or on behalf of another organisation such as RCPath and you belong to the BIA please do copy your form to BIA@Hartleytaylor.co.uk. Responders will receive a BIA Guideline Review Support Certificate which can be used to self-credit up to 10 CPD points for commenting on a consultation and we will incorporate your individual/other organisation response into the response of the BIA.
NICE draft guideline on cystic fibrosis: diagnosis and management
This draft guideline and its supporting evidence are now out for consultation. The consultation will close at 5pm on 18th June 2017. Please send your comments to Anna Goodman at Anna.Goodman@gstt.nhs.uk by 15th June to allow for an organisational response to be sent. The expected publication date for this guideline is October 2017.
RCOG GBS guideline for review
Please send comments to Anna Goodman at email@example.com by 28th April 2017.
In the absence of any views otherwise by 2pm on 28th April the BIA response will state that we would urge strengthening of the recommendation to women to have GBS testing in section 5.1
NICE: Implementation of changes to the arrangements for evaluating and funding drugs and other health technologies appraised through our technology appraisal (TA) and highly specialised technologies (HST) programmes
I am writing to you to make you aware of the implementation of changes to the arrangements for evaluating and funding drugs and other health technologies appraised through our technology appraisal (TA) and highly specialised technologies (HST) programmes effective from 01 April 2017.
In October 2016, we (NICE) launched a joint consultation with NHS England. In the consultation we proposed to:
- Operate a ‘budget impact threshold’ of £20 million, set by NHS England, to signal the need for a dialogue with companies to agree arrangements to better manage the introduction of new technologies recommended by NICE. This would apply to a small number of technologies that, once determined as cost effective by NICE, would have a significant impact on the NHS budget.
- Introduce a ‘fast track’ technology appraisal process for the most promising new technologies. These would fall below an incremental cost-effectiveness ratio of £10,000 per QALY (quality adjusted life year), to get these treatments to patients more quickly.
- Vary the timescale for the funding requirement when the budget impact threshold is reached or exceeded, and there is therefore a compelling case that the introduction of the new technology would risk disruption to the funding of other services.
Proposed changes to our drug evaluation process were put forward to the NICE Board for approval at their meeting on 15 March 2017.
If you responded to the consultation, we would like to take the opportunity to thank you for your valued contribution.
We’ve listened carefully to what stakeholders have been told us within the consultation and made some important changes, as well as adding detail to our proposals. Significantly, we will look at the feasibility of extending the fast-track appraisal process to a wider group of treatments – not just those with a likely cost per QALY of £10,000 or less.
What was previously known as the Abbreviated Technology Appraisal (ATA) process has also been absorbed into the Fast Track Appraisal (FTA) process, with the addition of ‘cost comparison’ methodology.
The NICE board also agreed proposals to introduce a £20 million budget impact test. The test will be used to trigger discussions about potential ‘commercial agreements’ between NHS England and companies in order to manage the budget impact of introducing high cost treatments. This will apply to both the technology appraisal (TA) and highly specialised technologies (HST) programmes
The following documentation is now available on the NICE website:
· October 2016; Joint consultation document
· March 2017; NICE Board paper
· March 2017; Consultation analysis
· April 2017; Procedure for varying the funding requirement to take account of net budget impact
· April 2017; Assessing resource impact process manual: technology appraisals and highly specialised technologies
· April 2017; Fast track appraisal - Addendum to the Guide to the Processes of Technology Appraisal
· April 2017; Cost comparison - Addendum to the Guide to the methods of Technology Appraisal
Existing submission templates have been updated to address the implementation of the changes, and new templates for the application of the cost comparison methodology are also available on the NICE website.
If you have any questions about these changes, please contact Jenniffer Prescott, Associate Director (Planning, Operations and Topic Selection) by email at firstname.lastname@example.org.
Stakeholder Consultation High Consequence Infectious Diseases (Airborne) Interim
This two week consultation closes on 27th March 2017 - NOW EXTENDED TO FRIDAY 31/03/17; SEE BELOW
This is a service specification that sets out the heightened state of preparedness in which a Trust should be so that they are able to treat a patient who has a high consequence airborne infectious disease.
In 2015/16, NHS England established the High Consequence Infectious Disease (HCID) Programme. The objective of the programme is to ensure that there is an agreed approach to managing the end to end patient pathway for known and unknown high consequence infectious diseases (suspected and confirmed). This is turn will ensure that a sustainable response is in place, and is efficiently and effectively actionable, should the need arise.
If you would like to respond to this consultation and require the response form to complete, please email email@example.com
The following statement from Anna Goodman was posted on 28/03/17:
The two week consultation on the High Level Isolation Unit for High Consequence Infectious Diseases, (Airborne) Adult consultation closed yesterday. This was a proposal as to the remit of specific units. The proposal is for 4 units which would each care for approximately up to 4 patients with confirmed high consequence airborne infections per year, receiving patients within 6 hours of confirmed diagnosis and providing critical care support. It does not refer to the care of those more numerous patients who are considered possibly infected with such pathogens. I have been informed that stakeholder comments can be submitted until the end of this week and will be considered.
The BIA has currently submitted a response without comments and I am aware that some of you have submitted your comments from your own organisations or as individuals.
Given we have extra time and the fact that I was unable to send the entire large document to everyone to avoid blocking their inboxes I would be happy to take any comments that you would like submitted by the BIA until 5pm on Friday to me by email at firstname.lastname@example.org . For the documents which you would need in order to comment please request them by email to email@example.com who will reply with them attached- they have not been sent out routinely.
NICE Quality Standard consultation: Sepsis
This consultation is open from 10 March - 07 April 2017; however, we would very much appreciate if responses are sent to Anna Goodman at Anna.Goodman@gstt.nhs.uk by 30th March to allow for a coordinated BIA response to be sent.
Note from Anna Goodman, BIA Guidelines Secretary, about this QS consultation:
I have had a lot of comments on this standard. Thank you to all those who have responded. I have concluded we cannot support in its current form. We were asked for comments previously as I found and it seems our comment (which came from me) was solely the need to incorporate qSOFA- which they haven’t done.
I will submit this next week.
Mycology Laboratory Diagnostic Capacity Survey: ESPAUR/PHE/BSMM
The following survey is designed to help Public Health England (PHE) and the British Society for Medical Mycology (BSMM) understand current mycology laboratory practice and capabilities throughout the UK, following updated BSMM standards for diagnosis of serious fungal diseases in 2015. The survey was created with the support of the UK Clinical Mycology Network (UK CMN).
The results of this survey will help to raise awareness of antifungal diagnostics, identify areas of improvement for the management of serious fungal diseases and inform national antifungal surveillance activities.
The survey may take around 10-15 minutes to complete. Please complete the survey in one sitting. The survey will close on 08/05/2017.
Thank you for taking the time to complete this questionnaire.
If you have queries about this questionnaire, please contact AMR@phe.gov.uk
BTS Guidelines for the diagnosis and management of non-tuberculosis mycobacterial pulmonary disease
Responses are urgently required to the NTM consultation by Sunday 12TH MARCH 2017
The draft British Thoracic Society Guideline for the diagnosis and management of non-tuberculosis mycobacterial disease has been posted on the BTS website for public consultation. This document has been prepared by a sub-committee of the BTS Standards of Care Committee (SOCC) in line with the Society’s policy for Guideline production - click for further info.
Flu vaccination: increasing uptake
The public registration facility to observe the committee meeting for Flu vaccination: increasing uptake will open on Wednesday 22 February 2017 on the NICE website.
If you would like to register for this committee meeting, please do so via the following web page: https://www.nice.org.uk/event/phacb-march-2017. Registration for this meeting will close on Wednesday 8 March 2017 at 5pm. Please note we may be unable to accept late requests to observe this meeting.
As a public observer, you will be able to listen to the business of the meeting, except where confidential information is being discussed, however, you will not be able to:
· participate in committee discussions
· ask questions, take part in voting or put your views to members of the committee
For further information about meetings in public please refer to the following document: Common questions and answers about meetings in public.
Should you have any queries regarding observing this meeting, please contact the Meetings in Public Coordinator, Jon Littler Jonathan.Littler@nice.org.uk
NICE draft scope consultation – Chronic obstructive pulmonary disease in over 16s
This is a consultation to comment on the draft scope.
The question of importance to BIA members is (2.7) What is the clinical and cost effectiveness of prophylactic oral antibiotics for preventing exacerbations in people with stable COPD?
I think most people in the BIA would agree that this is an appropriate question so I plan to respond on behalf of the organisation stating that we support the draft scope. If people have other comments eg; a wish to include antibiotic treatment considerations, you may find these are covered in other NICE guidance such as ‘Respiratory tract infections (self-limiting): prescribing antibiotics (2008) NICE guideline CG69’ please advise accordingly.
I will respond on 24th February so if members have comments please let me know before then. All responses to Anna.Goodman@gstt.nhs.uk.
UK National Screening Committee consultation: screening for Group B Streptococcus in pregnancy. Consultation closed 25/01/17. Expected review completion date: March 2017.
Bezlotoxumab for preventing recurrent Clostridium difficile infection ID1068. Consultation closed 19/12/16
NICE Quality Standard Topic Engagement Exercise: HIV testing: encouraging uptake. Consultation closed 5/12/16.
NICE QS topic engagement exercise: Sepsis. Consultation closed 16/11/16.
NICE guideline on Managing Common Infections. Consultation closed 28/11/16. Expected publication date tbc.
NICE Quality Standard Consultation: Vaccine uptake in under 19's. Consultation closed 29/09/16. Expected publication date: January 2017.
NICE Diagnostics Consultation Document: Integrated multiplex PCR tests for identifying gastrointestinal pathogens in people with suspected gastroenteritis (xTAG Gastrointestinal Pathogen Panel, FilmArray GI Panel and Faecal Pathogens B assay). Consultation closed 09/09/16. Expected publication date: January 2017.
NICE guideline CG139 Healthcare-associated infections: prevention and control in primary and community care. Consultation on the decision NOT to update this guideline closed 02/09/16.
NICE Consultation on Abbreviated Technology Appraisal (ATA) Process. Consultation closed 24/08/16. Comments are currently being reviewed and an updated version is due to be presented to the NICE board in November 2016.
RCPath guidance on the communication of critical results. This document was produced by Dr Bernie Croal. This document was online for consultation from 20 July to 17 August 2016 and the author is now considering the feedback. Click for consultation document.
Report from the EUCAST Subcommittee on the role of whole genome sequencing (WGS) in antimicrobial susceptibility testing. Consultation closed 24/06/16.
NICE Guideline: Sickle cell disease: managing acute painful episodes in hospital - Surveillance consultation. Consultation closed 02/06/16. Anticipated review decision publication: August 2016
UK SMI V 37: Chlamydia trachomatis infection - testing by Nucleic Acid Amplification Tests (NAAT). Consultation closed 31/05/16. Feedback currently being analysed.
NICE draft guideline consultation: Multimorbidity: clinical assessment and management. Guideline published September 2016.
NICE Quality Standard consultation: Hip fracture (update). Consultation closed 5/5/16. Anticipated publication: November 2016.
NICE Quality Standards (update): Diabetes in adults. Update published August 2016. Click for BIA response.
NICE draft guideline consultation: Non-Hodgkin's lymphoma. Guideline published July 2016.
Nice quality standard topic engagement exercise: blood transfusion. Consultation closed 01/03/16. Anticipated publication: Dec 2016
NICE draft guideline consultation: Sepsis. Guideline published July 2016.
NICE quality standard consultation: Bronchiolitis in children. Quality standard published June 2016
NICE guidelines - Cirrhosis in over 16s: assessment and management. Guidelines published July 2016
Survey on UK-wide provision of travel medicine training. Survey closed 6 January 2016.
NICE draft guideline consultation: Improving supportive and palliative care in adults (update). Consultation closed 28 January 2016.
NICE survey on diagnostic services: current practice. Consultation closed 29 January 2016.